Tiracizine (hydrochloride)
Tiracizine hydrochloride (AWD-19-166) is a Class I antiarrhythmic drug with activity that reduces myocardial contractile function. Tiracizine hydrochloride was studied in patients with ischemic heart disease, showing its effects on the myocardium. Tiracizine hydrochloride reduces myocardial contractility and may have potential use in the management of heart disease[1].
Product Specifications
CAS Number
78816-67-8
Product Name Alternative
AWD-19-166; GS 015
UNSPSC
12352005
Target
Endogenous Metabolite
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Neuroscience-Neuromodulation
Field of Research
Cardiovascular Disease
Smiles
O=C(NC1=CC=C2C(N(C3=C(CC2)C=CC=C3)C(CN(C)C)=O)=C1)OCC.Cl
Molecular Formula
C21H26ClN3O3
Molecular Weight
403.90
References & Citations
[1][Correction of the cardiotoxic effect of the anti-arrhythmia agents with befol, sufan, and their combination]
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
IgA Secretory Component (SC05), CF640R conjugate, 0.1mg/mL
